Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Industry

Prime Minister Carney Expands Canada-Ireland Partnership in Science, Technology, and Pharma

Sreepriya Prasannan
Sreepriya Prasannan

NewsWritten by our team from the primary sources linked below. Reviewed, verified and approved by a human editor. How we check

Speed:
Prime Minister Carney Expands Canada-Ireland Partnership in Science, Technology, and Pharma

DUBLIN, Ireland - In a move designed to strengthen transatlantic ties and foster innovation, Canadian Prime Minister Mark Carney has concluded a historic bilateral visit to Ireland-the first by a Canadian Prime Minister in nearly a decade. Meeting with Taoiseach Micheál Martin, the leaders unveiled a sweeping new joint statement prioritizing cooperation across artificial intelligence (AI), regenerative medicine, biomanufacturing, and global food security.

The visit underscores a flourishing relationship between the two nations, buoyed by a 150% growth in bilateral trade over the past decade. With the world facing increasingly complex supply chain and health challenges, this expanded partnership positions Ireland and Canada as joint leaders in the global life sciences and technology sectors.

Accelerating AI and Digital Innovation

A central pillar of the renewed partnership is the commitment to harness the artificial intelligence revolution. By aligning Canada’s AI for All strategy with Ireland’s Digital Ireland framework, both countries aim to accelerate the ethical application of AI to improve healthcare outcomes, streamline pharmaceutical manufacturing, and drive economic growth.

The immediate impact of this alignment was highlighted by the announcement that Canada-based tech giant OpenText is investing over $160 million to establish its European AI hub in Cork, Ireland. This major investment is expected to create highly skilled jobs and serve as a catalyst for digital innovation within the European Union.

Strengthening Resilient Health Systems & Biomanufacturing

The global pandemic underscored the critical need for robust health systems and secure pharmaceutical supply chains. Addressing this, Prime Minister Carney and the Taoiseach announced significant collaborations focused on regenerative medicine, biomanufacturing skills, and workforce development.

Two major Memoranda of Understanding (MOUs) were signed to cement this cooperation:

  • CCRM Ireland Hub: The Toronto-based Centre for Commercialization of Regenerative Medicine (CCRM) signed an MOU with Ireland’s RINN Advanced Therapies national research centre. This partnership will explore establishing a CCRM hub in Ireland, aiming to accelerate the development and commercialisation of innovative health technologies and advanced therapies.
  • Biopharma Workforce Development: The Canadian Alliance for Skills and Training in Life Sciences (CASTL) partnered with Ireland’s National Institute for Bioprocessing Research and Training (NIBRT). This strategic MOU will expand joint training programs, ensuring a steady pipeline of highly skilled talent for the rapidly growing biopharmaceutical sector in both nations.

Commercial Expansion and Investment in Pharma

The bilateral visit also served as a backdrop to highlight major commercial agreements between Canadian and Irish enterprises, reinforcing the robust economic ties between the two countries. Key announcements included:

  • Smurfit Westrock Expansion: Irish packaging giant Smurfit Westrock committed to a $110 million investment in its Canadian operations by 2030. The company currently employs 4,000 people across five facilities in Canada, providing essential packaging solutions that support the broader pharmaceutical and agri-food supply chains.
  • Healthcare Infrastructure: Canadian construction and healthcare infrastructure firm EllisDon announced its expansion into Ireland. The company will support the establishment of state-of-the-art healthcare facilities for Ireland’s Health Service Executive (HSE) and related stakeholders, bringing Canadian expertise to Irish healthcare infrastructure projects.

Climate Action and Global Food Security

Beyond technology and healthcare, the leaders emphasized their shared responsibility in tackling global challenges. The partnership includes a joint initiative on global food security and agriculture, leveraging Canada's National Food Security Strategy. Furthermore, both nations pledged to accelerate climate cooperation, specifically targeting clean technologies and methane mitigation through multilateral forums.

Cultural Heritage and Security Cooperation

Recognizing the deep historical connections between the two countries, Prime Minister Carney announced a $2 million contribution toward Canada-Ireland 180, a cultural initiative slated for 2027. This landmark event will commemorate the 180th anniversary of the mass migration of over 100,000 Irish people to Canada, celebrating shared heritage and empowering Irish-Canadian artists.

Additionally, the leaders committed to enhancing security and defence cooperation, exploring practical maritime security training between the Canadian Armed Forces and the Irish Defence Forces under the Canada-EU Security and Defence Partnership.

A Transatlantic Worldview

Following his engagements in Dublin, Prime Minister Carney travelled to County Mayo-a region with profound historical ties to Canada-where he met with Irish President Catherine Connolly and local community leaders. The visit to Ireland directly followed Prime Minister Carney's meetings in Paris, highlighting a broader strategy to solidify Canada's alliances across Europe.

"With our common history and shared values, Canada and Ireland have developed a unique transatlantic worldview rooted in a simple conviction: we are stronger when we are connected. With this deeper cooperation, we are building new opportunities for our people. Together, we will be powerful, pivotal, and a purposeful force for good - reliable partners in a world that is anything but."

- The Rt. Hon. Mark Carney, Prime Minister of Canada

With bilateral merchandise trade reaching $6 billion in 2025, and Ireland standing as a critical gateway for Canadian businesses into the EU, this expanded partnership marks a significant milestone. For the life sciences and technology sectors, the agreements forged during this visit promise to drive innovation, secure supply chains, and create lasting economic value on both sides of the Atlantic.

Reviewed for editorial accuracy by Sreepriya Prasannan, Founder & Editor MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany
Our standards
Drugs in this article: current clinical trials
Most-trialled drugs in our registers
Browse all trial registers →

Get the Friday brief

One email every Friday: a 60-second summary, then only the topics you choose: industry news, approvals and market access, shortages, Irish trials, careers or data, all built from public registers.

Free. Unsubscribe from any email with one click. See our privacy policy.

About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · Industry

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment